CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 43,179 shares at $19.49 ($838K) on 2016-06-24, disclosed to the SEC on 2016-06-28.
Open-market purchase of $838k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.35 | 3,014 | $55K | 6.6% |
| 2 | $19.49 | 2,712 | $53K | 6.3% |
| 3 | $19.49 | 2,728 | $53K | 6.3% |
| 4 | $19.49 | 9,921 | $193K | 23.1% |
| 5 | $19.49 | 10,418 | $203K | 24.2% |
| 6 | $19.49 | 14,386 |
| $280K |
| 33.5% |
| Total | $19.41 avg | 43,179 | $838K | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |